Hadar Goldvaser

Oncology

1101 Hempstead Tpke
Uniondale, NY 11553

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.

Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.

Journal: Cancers

Published: May 26, 2026

A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor-Positive Metastatic Breast Cancer.

A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor-Positive Metastatic Breast Cancer.

Journal: Cancer research communications

Published: February 20, 2026

Managing healthcare for female BRCA carriers in the population screening era: developing a harmonized national policy for surveillance and risk-reduction.

Managing healthcare for female BRCA carriers in the population screening era: developing a harmonized national policy for surveillance and risk-reduction.

Journal: Israel journal of health policy research

Published: August 08, 2025

Heterogeneity of Primary Outcomes in Large Atherosclerotic Cardiovascular Disease Trials Published in Prominent Medical Journals.

Heterogeneity of Primary Outcomes in Large Atherosclerotic Cardiovascular Disease Trials Published in Prominent Medical Journals.

Journal: JAMA internal medicine

Published: February 17, 2025

Direct-to-implant Prepectoral Breast Reconstruction in Women Older Than 65 Years: Analysis of Safety and Patient-reported Outcome.

Direct-to-implant Prepectoral Breast Reconstruction in Women Older Than 65 Years: Analysis of Safety and Patient-reported Outcome.

Journal: Plastic and reconstructive surgery. Global open

Published: August 30, 2024

De-escalation of surgical and radiation treatment in elderly luminal breast cancer patients, single institution report and review of the evidence.

De-escalation of surgical and radiation treatment in elderly luminal breast cancer patients, single institution report and review of the evidence.

Journal: World journal of surgical oncology

Published: August 14, 2024

Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort.

Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort.

Journal: Breast cancer (Tokyo, Japan)

Published: August 12, 2024

ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.

ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.

Journal: Breast cancer research and treatment

Published: June 11, 2024

The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review.

The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review.

Journal: Critical reviews in oncology/hematology

Published: April 25, 2024

The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy.

The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy.

Journal: Breast cancer research and treatment

Published: November 12, 2023

Reporting of post-protocol therapies in metastatic breast cancer registration clinical trials: A systematic review.

Reporting of post-protocol therapies in metastatic breast cancer registration clinical trials: A systematic review.

Journal: Cancer treatment reviews

Published: September 18, 2023

Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy.

Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy.

Journal: Biomedicines

Published: April 25, 2023

Showing 1-12 of 75

Last Updated: 09/26/2026